Tubiferal A, a backbone-rearranged triterpenoid lactone isolated from the myxomycete Tubifera dimorphotheca, possessing reversal of drug resistance activity

Tetrahedron

Volumn 60, Issue 44, 2004, Pages 9835-9839

  Kamata, Kazuaki ^a   Onuki, Hiroyuki ^b   Hirota, Hiroshi ^b   Yamamoto, Yukinori ^c   Hayashi, Masahiko ^d   Komiyama, Kanki ^d   Sato, Masaaki ^a   Ishibashi, Masami ^a  

^a CHIBA UNIVERSITY   (Japan)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

^c Japan ^*  (Japan)

^d KITASATO INSTITUTE   (Japan)

Author keywords

Myxomycete; Rearranged triterpenoid; Reveasal of drug resistance; Tubifera dimorphotheca

Indexed keywords

BUIFERAL A; LACTONE DERIVATIVE; TRITERPENOID LACTONE; TUBIFERAL A; UNCLASSIFIED DRUG; VINCRISTINE;

ANTIBIOTIC RESISTANCE; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG ISOLATION; DRUG STRUCTURE; HUMAN; HUMAN CELL; MYXOMYCETES; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS; TUBIFERA DIMORPHOTHECA;

DIMORPHOTHECA; TUBIFERA;

EID: 4644362700     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tet.2004.08.071     Document Type: Article

References (18)

1. W. Steglich Pure Appl. Chem. 61 1989 281 288
2. Ishibashi, M. Studies in Natural Products Chemistry; Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 2003; Vol. 29, pp 223-262.
3. S. Nakatani, Y. Yamamoto, M. Hayashi, K. Komiyama, and M. Ishibashi Chem. Pharm. Bull. 52 2004 368 370
4. D. Iwata, M. Ishibashi, and Y. Yamamoto J. Nat. Prod. 66 2003 1611 1612
5. S. Nakatani, A. Naoe, Y. Yamamoto, T. Yamauchi, N. Yamaguchi, and M. Ishibashi Bioorg. Med. Chem. Lett. 13 2003 2879 2881
6. Y. Misono, Y. Ishikawa, Y. Yamamoto, M. Hayashi, K. Komiyama, and M. Ishibashi J. Nat. Prod. 66 2003 999 1001
7. Y. Misono, A. Ito, J. Matsumoto, S. Sakamoto, K. Yamaguchi, and M. Ishibashi Tetrahedron Lett. 44 2003 4479 4481
8. Y. Misono, M. Ishibashi, and A. Ito Chem. Pharm. Bull. 51 2003 612 613
9. A. Naoe, M. Ishibashi, and Y. Yamamoto Tetrahedron 59 2003 3433 3435
10. Y. Ishikawa, M. Ishibashi, Y. Yamamoto, M. Hayashi, and K. Komiyama Chem. Pharm. Bull. 50 2002 1126 1127
11. M. Ishibashi, T. Iwasaki, S. Imai, S. Sakamoto, K. Yamaguchi, and A. Ito J. Nat. Prod. 64 2001 108 110
12. P.M. Dewick Medicinal Natural Products: A Biosynthetic Approach 2nd ed. 2002 Wiley Chinchester pp 234-236
13. G. Kusano, H. Uchida, Y. Murakami, N. Sakurai, and T. Takemoto Yakugaku Zasshi 96 1976 321 325
14. An acerinol-related compound was once reported to have been isolated from Cimicifuga heracleifolia without acid treatment: J.X. Li, S. Kadota, M. Hattori, S. Yoshimachi, M. Shiro, N. Oogami, H. Mizuno, and T. Namba Chem. Pharm. Bull. 41 1993 832 841
15. M.-C. Rho, M. Hayashi, A. Fukami, R. Obata, T. Sunazuka, H. Tomoda, K. Komiyama, and S. mura J. Antibiot. 53 2000 1201 1206
16. M. Hayashi, K. Koike, M.-C. Rho, M. Kuwano, T. Kishie, and K. Komiyama Anti-Cancer Drug Des. 16 2001 255 260
17. M.C. Alley, D.A. Scudiero, A. Monks, M.L. Hursey, M.J. Czerwinski, D.L. Fine, B.J. Abbott, J.G. Mayo, R.H. Shoemaker, and M.R. Boyd Cancer Res. 48 1998 589 601
18. R.D. Fields, and M.V. Lancaster Am. Biotechnol. Lab. 11 1993 48 50